Electronic International Standard Serial Number (EISSN)
PurposeMyocardial uptake can hamper visualization of lung tumors, atherosclerotic plaques, and inflammatory diseases in 2-deoxy-2-[F-18]fluoro-D-glucose ([F-18]FDG) studies because it leads to spillover in adjacent structures. Several preparatory pre-imaging protocols (including dietary restrictions and drugs) have been proposed to decrease physiological [F-18]FDG uptake by the heart, although their effect on tumor glucose metabolism remains largely unknown. The objective of this study was to assess the effects of a ketogenic diet (as an alternative protocol to fasting) on tumor glucose metabolism assessed by [F-18]FDG positron emission tomography (PET) in a mouse model of lung cancer.ProceduresPET scans were performed 60min after injection of 18.5MBq of [F-18]FDG. PET data were collected for 45min, and an x-ray computed tomograph (CT) image was acquired after the PET scan. A PET/CT study was obtained for each mouse after fasting and after the ketogenic diet. Quantitative data were obtained from regions of interest in the left ventricular myocardium and lung tumor.ResultsThree days on a ketogenic diet decreased mean standard uptake value (SUVmean) in the myocardium (SUVmean 0.950.36) more than one night of fasting (SUVmean 1.64 +/- 0.93). Tumor uptake did not change under either dietary condition.Conclusions p id=Par4 These results show that 3days on high-fat diets prior to [F-18]FDG-PET imaging does not change tumor glucose metabolism compared with one night of fasting, although high-fat diets suppress myocardial [F-18]FDG uptake better than fasting.